As NO is regarded as a biomarker of inflammatory activity in colonic disease, immunoreactivity of iNOS and IL-1β (e.g., as by promoting iNOS expression) was hypothesized to predict CAC prognosis. This evidence concerns the gene NOS2 and colonic disorder.